Stress cardiomyopathy as a cardiovascular manifestation of COVID-19

Khaled M Abdullah; Mohamad Bakir; Danielle Greenberg; Eyad Almasri

doi:10.21542/gcsp.2023.29

Stress cardiomyopathy as a cardiovascular manifestation of COVID-19

Glob Cardiol Sci Pract. 2023 Sep 30;2023(4):e202329. doi: 10.21542/gcsp.2023.29.

Authors

Khaled M Abdullah¹, Mohamad Bakir², Danielle Greenberg¹, Eyad Almasri³

Affiliations

¹ UCSF Fresno, San Francisco, USA.
² Alfaisal University, College of Medicine, Riyadh, Saudi Arabia.
³ UCSF Fresno, Pulmonary/Critical Care, San Francisco, USA.

Abstract

Patients with coronavirus disease 2019 (COVID-19) may present with a broad spectrum of clinical manifestations, affecting several organ systems. Predominant cardiac manifestations include myocardial injury, heart failure, cardiogenic shock, and arrhythmias. Stress (takotsubo) cardiomyopathy, characterized by apical ballooning of the heart leading to acute left ventricular dysfunction, is rarely seen in patients with COVID-19. We present a case of COVID-19-associated stress cardiomyopathy in a female in her sixties.

Publication types

Case Reports